Akèy › Limfadenopati Imunoblastik › Illinois › Chicago
Etid klinik pou Limfadenopati Imunoblastik nan Chicago, IL
4 etid pou Limfadenopati Imunoblastik ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Ap rekriteFaz 2
- Northwestern University, Chicago
- University of Illinois, Chicago
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
- North Western University Robert H. Lurie Comprehensive Cancer Center RHLCCC, Chicago
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- Northwestern Medicine (Data Collection), Chicago
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago
Etid Limfadenopati Imunoblastik nan lòt vil
- New York City, NY5 etid
- Houston, TX4 etid
- Miami, FL4 etid
- Durham, NC4 etid
- Baldwin Park, CA3 etid
- Ann Arbor, MI3 etid
- New Haven, CT3 etid
- Columbus, OH3 etid
- Atlanta, GA3 etid
- Boston, MA3 etid
- St. Louis, MO3 etid
- Rochester, MN3 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete58 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Obèsite41 etid
- Kansè poumon41 etid
- Kansè ovè36 etid
- Akidan serebavaskilè34 etid
- Kansè kolorektal33 etid
- Ensifizyans kadyak31 etid
- Sipwa28 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.